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SUMMARY
While we have considerable understanding of the transcriptional networks controlling mammalian
cell differentiation, our knowledge of post-transcriptional regulatory events is very limited. Using
differentiation of primary erythroid cells as a model, we show that the sequence-specific mRNA-
binding protein Cpeb4 is strongly induced by the erythroid important transcription factors Gata1
and Tal1 and is essential for terminal erythropoiesis. By interacting with the translation initiation
factor eIF3 Cpeb4 represses the translation of a large set of mRNAs, including its own mRNA.
Thus transcriptional induction and translational repression combine to form a negative feedback
loop to control Cpeb4 protein levels within a specific range that is required for terminal
erythropoiesis. Our study provides an example of how translational control is integrated with
transcriptional regulation to precisely control gene expression during mammalian cell
differentiation.
INTRODUCTION
Gene regulation during development is regulated at multiple transcriptional and post-
transcriptional levels, including control of mRNA translation and degradation. Whereas a
great deal is known about the transcriptional regulatory networks that control cell type
specificity and differentiation, much less is understood about the post-transcriptional
regulatory circuits that are essential for mammalian development, particularly somatic cell
differentiation. Here we use terminal erythropoiesis as a system to explore post-
transcriptional events that control an important terminal cell differentiation pathway.
During the final stage of erythropoiesis, the erythropoietin (Epo)-responsive erythroid CFU-
E (colony forming unit erythroids) progenitors undergo dramatic changes in morphology
and in protein expression. In the presence of Epo, CFU-Es divide 4–5 times and undergo
dramatic decreases in both nuclear and cell sizes, chromatin condensation,
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hemoglobinization, and ultimately extrusion of the nuclei, forming enucleated reticulocytes.
These changes are accompanied by significant transcriptome reprogramming; ~600 genes
are induced and ~6000 genes are repressed at the RNA level during terminal erythroid
differentiation (Wong et al., 2011). These transcriptomic changes are mediated by several
key erythroid-important transcription factors, including Gata1, Tal1, and EKLF, as well as
by the Epo-Epo receptor-Jak2 -Stat5 signaling pathway (Hattangadi et al., 2011; Kerenyi
and Orkin, 2010). Much less is known concerning post-transcriptional regulation of gene
expression.
Here we used primary mouse fetal liver cells to explore the post-transcriptional regulatory
events in terminal erythroid differentiation. From embryonic days 12–16 (E12–16), mouse
fetal liver is the primary site of erythropoiesis. Most (90%) fetal liver cells are in the
erythroid lineage, providing us with a relatively pure source of erythroid cells. Erythroid
cells at different developmental stages (BFU-Es, CFU-Es, and mature Ter119+ cells) can be
purified using different combinations of cell surface markers (Flygare et al., 2011). Cultured
late erythroid progenitor cells, predominantly CFU-Es, undergo terminal proliferation and
differentiation into enucleated reticulocytes in vitro in a fashion that recapitulates terminal
erythropoiesis in vivo (Ji et al., 2008; Zhang et al., 2003). Critically, transcriptomes,
chromatin modifications, and genomic occupancies by erythroid important transcription
factors have been well documented in mouse fetal liver erythroid cells at different stages of
differentiation (Alvarez-Dominguez et al., 2013; Pilon et al., 2011; Wong et al., 2011).
These methods and resources make terminal differentiation of mouse fetal liver erythroid
progenitors an ideal system to investigate the interrelationships between transcriptional and
post-transcriptional regulatory circuits in mammalian cell development.
Here, using genomic approaches, we identified a sequence-specific RNA-binding protein,
Cpeb4, which is dramatically induced in terminal erythroid differentiation by two erythroid
important transcription factors, Gata1 and Tal1. Cpeb4 belongs to the cytoplasmic
polyadenylation element binding (CPEB) protein family that in mammals has four members,
Cpeb1–4. All CPEB proteins in mammals have RNA-binding domains in their carboxy-
termini that are responsible for binding to their substrate mRNAs via recognition of specific
sequences in the 3’ untranslated region (3’UTR) (Fernandez-Miranda and Mendez, 2012;
Huang et al., 2006). Mechanistically, CPEB proteins are best characterized as translational
activators through elongating poly(A)-tails of target mRNAs via recruiting cytoplasmic
poly(A) polymerases, although CPEB proteins can also repress translation (D’Ambrogio et
al., 2013; Fernandez-Miranda and Mendez, 2012). Functionally, despite involvement in
many biological processes (e.g. embryo development, neuronal activity, cancer)
(D’Ambrogio et al., 2013; Fernandez-Miranda and Mendez, 2012), CPEB proteins’ roles in
somatic cell differentiation still remain to be explored.
Here we show that Cpeb4 is induced by the erythroid important transcription factors Gata1
and Tal1, is strongly upregulated during terminal erythroid development, and is essential for
terminal erythropoiesis. By binding directly to the translation initiation factor eIF3 complex,
Cpeb4 represses the translation of a large set of mRNAs, most of which are normally
downregulated during terminal erythroid development. Cpeb4 also binds to its own mRNA
to repress its translation, and ectopic expression of Cpeb4 blocks erythroid differentiation.
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Thus transcriptional induction and translational repression combine to form a negative
feedback loop to control Cpeb4 protein levels within a specific range that is required for
terminal erythropoiesis. Our study provides an example of how translational control is
integrated with transcriptional regulation to precisely control gene expression during
mammalian cell differentiation.
RESULTS
Identification of RNA-binding Proteins Enriched in Terminal Differentiating Erythroblasts
RNA-binding proteins (RBPs) play important roles in post-transcriptional regulation of gene
expression. Interestingly, ENCODE expression profiles revealed that mammalian RBPs are
differentially expressed among different cells and tissues and that many RBPs are highly
cell-type specific (Figure S1A) (Stamatoyannopoulos et al., 2012). These expression
patterns suggest that some RBPs are required for formation of specific cell types, but the
roles of most RBPs in mammalian cell differentiation are unknown. From the ENCODE
data we identified 49 RBPs that are enriched in fetal liver erythroblasts. Among these 49
RBPs, six are highly induced during terminal erythroid differentiation from the CFU-E stage
(Figure S1B). Here we focused on Cpeb4 because it is highly expressed in terminal
differentiating erythroblasts and is dramatically induced during terminal differentiation.
Among the four family members of CPEB proteins, only Cpeb4 is highly expressed in
mouse fetal liver terminally differentiating erythroblasts (Figure S1C), allowing us to
specifically characterize the function of this protein in erythroid development.
During terminal erythropoiesis Cpeb4 is Dramatically Induced by Gata1 and Tal1
To determine the expression pattern of Cpeb4 in erythropoiesis, we first fractionated total
E14 mouse fetal liver into five populations (R1-R5) using the cell surface markers CD71
(transferrin receptor) and Ter119 (glycophorin) (Figure 1A). R1 and R2 fractions are
enriched for erythroid progenitors, and R3-R5 contain successively differentiated
erythroblasts with R5 containing mostly enucleated reticulocytes (Zhang et al., 2003). Real-
time RT-PCR revealed that Cpeb4 mRNA is dramatically induced during the transition from
R2 to R3 (Figure 1B), congruent with the period when most of the ~600 erythroid-important
genes are upregulated (Wong et al., 2011). In our erythroid culture system (Zhang et al.,
2003), Cpeb4 protein levels peak at 24 hrs (Figure 1C), correlating well with the induction
of Cpeb4 mRNA and the appearance of hemoglobinized erythroblasts (Ji et al., 2008; Zhang
et al., 2003). Collectively, these results indicate that Cpeb4 mRNA and protein are
dramatically induced during terminal erythropoiesis.
To further determine whether Cpeb4 is specific to erythroid cells, we fractionated total
mouse fetal liver cells into different cell lineages and progenitors using cell surface markers
and then quantified the Cpeb4 mRNA level using real-time RT-PCR. Clearly, Cpeb4 is
highly enriched in terminal differentiating erythroblasts (Ter119+) compared to other cell
types (Figure 1D).
Two lines of evidence indicated that Cpeb4 mRNA is induced by Gata1 and Tal1, two
erythroid-important transcription factors. First, in published ChIP-seq (chromatin
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immunoprecipitation with high throughput DNA sequencing) datasets from primary mouse
fetal liver erythroblasts (Wong et al., 2011; Wu et al., 2011), there are several discrete
Gata1/Tal1 binding signals within 40kb of the Cpeb4 transcription start site (Figure 1E).
Interestingly, these Gata1/Tal1 occupancy sites correlate well with the transcription
enhancer marker H3K4me1 (Figure 1E), suggesting that Cpeb4 expression is regulated by
Gata1 and Tal1. Second, Gata1 activation in G1E cells is a well-established model for
studying Gata1-mediated regulation in erythropoiesis (Weiss et al., 1997); in this system
Gata1 binding to the Cpeb4 enhancer regions is temporally congruent with transcriptional
activation of Cpeb4 (Figure S2). Together, these observations indicate that Cpeb4 is a target
of Gata1/Tal1 in terminal erythropoiesis.
Cpeb4 is Required for Terminal Erythropoiesis
shRNA-mediated loss-of-function studies revealed that Cpeb4 is required for terminal
erythroid differentiation. Specifically, two shRNAs targeting different regions of Cpeb4
were introduced into Lin- cells via retroviral transduction. Most of these Lin- cells are CFU-
Es (Flygare et al., 2011). The transduced cells were first cultured in the maintenance
medium for 24 hours to allow shRNA expression and then switched to differentiation
medium. Both shRNAs efficiently knock down both Cpeb4 mRNA and protein levels in
differentiating erythroblasts, as compared to a scrambled shRNA control (Figure 2A).
Inhibition of Cpeb4 expression caused a marked inhibition of terminal cell proliferation, as
determined by counting the numbers of live cells (Figure 2B). To quantify the number of
cell divisions in Cpeb4 knockdown cells, we labeled cell membranes with an inert
fluorescence dye and then used flow cytometry to determine the fluorescence intensity of the
labeled cells at 24 hours and 48 hours in the differentiation medium. During each cell
division, the fluorescence dye is diluted by half; thus by comparing the fluorescence
intensity at each time point to the original fluorescence intensity, we can calculate how
many cell divisions have occurred. Clearly, the number of cell divisions in the Cpeb4
knockdown cells is significantly reduced (Figure 2C), suggesting that cell cycle progression
is comprised. To specifically examine the cell cycle, we pulse-labeled differentiating
erythroblasts with a reactive deoxynucleotide analog (EdU) to label S-phase cells, and used
a DNA dye to discriminate the cells in the G1 and G2/M phases (Figure 2D). Knockdown of
Cpeb4 caused cells to accumulate in the G1 phase, accompanied by a dramatic decrease in
the numbers of S phase cells (Figure 2D, 2E), indicating that cell proliferation was severely
compromised. In addition, there was a large increase of apoptotic cells (annexin-V positive)
following Cpeb4 knockdown (Figure 2F, 2G). Collectively, these results indicated that
Cpeb4 is required for proper cell cycle progression in terminal differentiating erythroblasts.
To further determine the changes of gene expression and the downstream differentiation
process in Cpeb4 knockdown erythroid cells, we used real-time RT-PCR to quantify the
expression of a group of erythroid-important genes induced during terminal differentiation.
Induction of these genes was blocked following Cpeb4 knockdown (Figure 2H).
Concomitantly, Cpeb4 knockdown cells contained much higher-than-normal levels of key
mRNAs normally downregulated during terminal differentiation (Figure 2I). These results
revealed that terminal erythroid differentiation in Cpeb4 knockdown cells was
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compromised. To directly assay the products of terminal erythropoiesis, we measured the
generation of enucleated reticulocytes by using a DNA dye to fractionate the cells with
nuclei and the enucleated cells. Simultaneously, the maturation of terminal differentiating
erythroblasts was monitored by Ter119 and CD71 staining. When Cpeb4 was inhibited, the
generation of enucleated reticulocytes was dramatically inhibited (Figure 3A, 3C). In
addition, the maturation of differentiating erythroblasts, as indicated by the CD71 and
Ter119 double position cell population, was also severely compromised (Figure 3B, 3C).
Collectively, these results indicate that induction of Cpeb4 is required for terminal erythroid
differentiation.
We believe that these phenotypes do not result from nonspecific effects of the Cpeb4
shRNAs and thus are specific to Cpeb4, because the severity of all these phenotypes
correlates well with the Cpeb4 knockdown efficiencies (Figure 2). Furthermore, when the
same two shRNAs were introduced into NIH3T3-L1 cells, where Cpeb4 is not expressed, no
phenotypic changes in the cells were observed (Figure S3).
Cpeb4 Interacts with eIF3 to Repress mRNA Translation in Erythroid Cells
CPEB proteins can both repress and activate target mRNA translation (Fernandez-Miranda
and Mendez, 2012). To determine how Cpeb4 regulates gene expression in erythroid cells,
we employed a tethering assay (Coller and Wickens, 2007). Using the strong and specific
interaction between the bacteriophage λN polypeptide and the BoxB RNA motif, we
tethered the λN-Cpeb4 fusion protein to the 3’UTR of a firefly luciferase reporter mRNA
(Figure 4A). The translatability of the reporter, defined as luciferase activity normalized to
luciferase mRNA level, was assayed in erythroleukemia cells (K562 cells). Interestingly,
tethering Cpeb4 significantly reduced the reporter’s translatability compared to tethering a
green fluorescence protein (GFP) to the 3’UTR of the reporter mRNA (Figure 4A). In
addition, there was no change in the luciferase reporter mRNA level (Figure S4A) when
Cpeb4 or GFP was tethered, indicating that the effect was predominantly accomplished by
translational inhibition. Importantly, translational repression was dependent on the BoxB
sites, since there was no change in the translatability of the control reporter lacking these
sites when the λN-Cpeb4 fusion protein was introduced (Figure 4A).This observation
indicates that inhibition of translatability requires the binding of Cpeb4 to the reporter
mRNA. These results revealed that Cpeb4 is a translation repressor in erythroid cells;
consistent with this notion, the two cytoplasmic poly(A) polymerases, Gld2 and Gld4, which
are required for CPEB protein-mediated translational activation (D’Ambrogio et al., 2013),
are not expressed in terminally differentiating erythroblasts (Figure S4B).
To identify the proteins that interact with Cpeb4 in erythroid cells, we performed affinity
purification followed by mass spectrometry. Specifically, we immunoprecipitated both
endogenous Cpeb4 from primary mouse fetal liver erythroblasts and an epitope-tagged
Cpeb4 expressed in K562 cells. This experiment was performed in the presence and absence
of RNaseA to discriminate RNA-independent and RNA-mediated interactions. In both types
of cells, mass spectrometry analyses identified several eIF3 subunits as the major translation
factors that directly associate with Cpeb4 (Figure S4D S4E, Table S1). Interestingly, Maskin
(Tacc3 in mouse) and eIF4E, which are used by Cpeb1 in Xenopus oocytes to repress
Hu et al. Page 5













mRNA translation (D’Ambrogio et al., 2013), were not detected, suggesting that Cpeb4 uses
a different mechanism to repress mRNA translation in erythroid cells.
The eIF3 complex is the largest and the most complicated translation initiation factor in
mammals with 13 non-identical subunits (eIF3a to eIF3m) that can regulate translation
initiation at multiple steps (Hinnebusch, 2006, 2014; Sonenberg and Hinnebusch, 2009). The
several eIF3 subunits (eIF3a, eIF3b, eIF3c, eIF3l) identified in our mass spectrometry
analysis suggested that Cpeb4 directly associates with the eIF3 complex in erythroid cells.
To further confirm this interaction, we used an antibody against eIF3a subunit to
immunoprecipitate the endogenous eIF3 complex from primary mouse fetal liver
erythroblasts (Figure 4B). Indeed, a different eIF3 subunit, eIF3b, was found to co-
immunoprecipitate with eIF3a (Figure 4B), indicating that this approach can isolate the eIF3
complex (or part of the eIF3 complex). Western blot analysis revealed that Cpeb4
specifically co-immunoprecipitated with the eIF3 complex and that this interaction is
independent of RNA (Figure 4B), indicating that Cpeb4 directly interacts with the eIF3
complex.
We hypothesized that since Cpeb4 interacts with a general translation initiation factor, if
expressed at high level Cpeb4 may repress global mRNA translation in erythroid cells. To
test this, we created a mouse erythroleukemia cell line (MEL) that overexpresses Cpeb4
(Figure 4C). We first examined global mRNA-ribosome associations by sucrose-gradient
mediated polyribosome profiling (Figure 4D). Interestingly, Cpeb4 overexpression resulted
in an obvious decrease of polyribosomes with a corresponding increase of 80S ribosomes
(Figure 4D), indicating an inhibition of translation initiation. Importantly, overexpression
just of the C-terminal segment of Cpeb4, which contains all of the RNA-binding domains
(Huang et al., 2006), does not influence global mRNA-ribosome association (Figure S4C).
This indicates that Cpeb4-mediated translation inhibition is not caused by general RNA
binding. To directly measure the global translation rate, we pulse-labeled cells with a non-
radioactive methionine analog and measured how fast it can be incorporated into
polypeptides in the MEL cells. We found that Cpeb4 overexpression reduced the global
translation rate to 80% of that in the control cells (Figure 4E). The different extents of
translation inhibition we observed from polyribosome profiling and the methionine
incorporation assay are probably due to the different aspects of translation these two assays
measure: mRNA-ribosome binding in the polysome profile vs. translation kinetics in the
methionine incorporation assay. Nonetheless, these results indicate that Cpeb4 can repress
mRNA translation in erythroid cells and suggest that the Cpeb4-eIF3 interaction is
functional.
We next showed that Cpeb4-mediated translation repression requires the eIF3 complex by
using an assay that measures translation from an internal ribosome entry site (IRES). IRES
elements are structured RNAs that are usually encoded by viral genomes to position and
activate eukaryotic translational initiation (Fraser and Doudna, 2007). Importantly, different
viral IRES elements require different sets of translation factors (Fraser and Doudna, 2007).
To study Cpeb4-mediated translation repression, we used the eIF3 dependent HCV IRES
and the eIF3 independent CrPV IRES (Fraser and Doudna, 2007). Specifically, a bicistronic
reporter was employed in which firefly luciferase (Fluc) is translated by cap-dependent
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translation and translation of renilla luciferase (Rluc) is controlled either by HCV-IRES or
CrPV-IRES mediated translation (Figure 4F). When these two reporters were transfected
into K562 cells (human erythroleukemia cells), as expected cap-dependent translation from
both reporters was repressed following Cpeb4 expression (Figure 4G), as determined by the
firefly luciferase activity. However, Cpeb4 only repressed HCV-IRES mediated translation
but did not affect CrPV-IRES mediated translation (Figure 4G). Since HCV-IRES requires
the eIF3 complex to initiate translation while CrPV-IRES does not, these results revealed
that Cpeb4-mediated translation repression is dependent on eIF3, indicating that the
repressive Cpeb4-eIF3 interaction is operative in erythroid cells.
Collectively, these experiments revealed that Cpeb4 is a translation repressor in erythroid
cells; it interacts with the generation translation initiation factor eIF3, and this interaction is
functionally relevant for Cpeb4-mediated translation repression.
Cpeb4 Represses the Translation of a Set of mRNAs, Including Its Own mRNA, during
Terminal Erythropoiesis
To identify the endogenous mRNA substrates that Cpeb4 regulates, we performed RNA
immunoprecipitation (RIP) followed by microarray (RIP-Chip) studies targeting endogenous
Cpeb4 in mouse primary fetal liver erythroblasts (Jain et al., 2011) (GEO: GSE57004). We
used three criteria to identify Cpeb4 substrate mRNAs from the microarray data. First, the
substrate mRNAs should be enriched at least 2.5 fold in the RIP sample versus the input.
Second, the substrate mRNAs must have higher signal intensity in the RIP sample compared
to that in the IgG control. Third, the substrates should be reproducibly detected in two
independent Cpeb4 RIPs. These criteria resulted in 227 putative Cpeb4 target transcripts
(Table S2).
Three lines of evidence indicate that the 227 mRNAs identified by RIP-Chip are Cpeb4
substrates in differentiating erythroblasts. First, all of the five known cytoplasmic
polyadenylation elements to which Cpeb4 can bind (Ortiz-Zapater et al., 2012) were
significantly enriched in the 3’UTRs of the 227 enriched mRNAs, compared to those of 503
control transcripts that were depleted in the Cpeb4 RIP-Chip (Figure 5A). Second, a uridine-
rich (U-rich) 8-nucleotide motif was statistically over-represented in the 3’UTRs of the 227
enriched mRNA compared to those in randomly selected mRNAs (Figure 5B). Critically,
this U-rich motif resembles the consensus Cpeb4 binding sequences identified from in vitro
binding studies (Huang et al., 2006; Ray et al., 2013). Third, we selected 16 mRNAs from
these 227 mRNAs for experimental verification. RIP followed by real-time RT-PCR
revealed that all 16 mRNAs were immunoprecipitated in significant amounts by an anti-
Cpeb4 antibody but not by the IgG control (Figure 5C). Importantly, Cpeb4 did not bind two
abundant control RNAs, Gapdh mRNA and 18S rRNA (Figure 5C), indicating that the
Cpeb4-mRNA interaction is specific. Collectively these results indicated that the 227
mRNAs are Cpeb4 substrates in differentiating erythroblasts. Gene ontology analysis
indicated that Cpeb4 substrates are enriched for mRNAs encoding protein kinases, nucleic
acid helicases, chromatin modifiers, and ubiquitin-domain containing proteins (Figure 5D),
suggesting that Cpeb4 can modulate expression of these factors in differentiating
erythroblasts.
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To determine the functional consequence of Cpeb4 binding to the target mRNAs, we
analyzed the distribution of Cpeb4 target mRNAs in MEL cells across a polyribosome
gradient both in the presence and absence of Cpeb4 expression (Figure 5E). When Cpeb4
was expressed, both endogenous Cpeb4 mRNA, as determined by real-time RT-PCR
targeting the 3’UTR, and Cdk6 mRNA shifted from the polyribosome to the 80S region
(Figure 5F), indicating translation inhibition of these two Cpeb4 substrate mRNAs.
Importantly, Cpeb4 expression did not change the distribution of Gapdh mRNA on the
gradient (Figure 5F), indicating the specificity of Cpeb4-mediated translational repression.
These results indicated that Cpeb4 binding results in translational inhibition of multiple
substrate mRNAs
Two lines of observations indicated that inhibiting the expression of Cpeb4 substrate
mRNAs is important for terminal erythropoiesis. First, downregulation of Cdk6 is known to
be required for terminal erythroid differentiation; while constitutive expression of Cdk6
blocks this differentiation process (Matushansky et al., 2000, 2003). Since Cdk6 mRNA is
translationally repressed by Cpeb4 in terminal differentiating erythroblasts, these results
partially explain why Cpeb4-mediated translation repression is important for terminal
erythropoiesis.
Second, we constitutively expressed 7 Cpeb4 substrate mRNAs, including Cdk6 mRNA, in
primary fetal liver erythroblasts, and then assayed terminal erythroid differentiation by
monitoring the formation of enucleated reticulocytes. We found that constitutive expression
of each of these Cpeb4 substrates blocks terminal erythroid differentiation (Figure S5A,
S5B). Importantly, constitutive expression of a control protein, renilla luciferase, had no
effect on this differentiation process (Figure S5A, S5B). These results suggest that down-
regulation of these Cpeb4 target genes is functionally important for terminal erythropoiesis.
Interestingly, the levels of most of the 227 Cpeb4 substrate mRNAs decrease monotonically
during terminal erythroid differentiation (Figure S5C), suggesting that Cpeb4-mediated
translation repression further ensures that the proteins encoded by these mRNAs are not
produced in terminally differentiating erythroblasts.
Maintaining Cpeb4 Protein Level within a Specific Range is Required for Terminal
Erythropoiesis
One striking finding is that Cpeb4 can bind to a large amount of its own mRNA (Figure 5C),
suggesting that Cpeb4-mediated negative translational regulation functions in a circuit with
Gata1/Tal1-mediated transcriptional induction to control Cpeb4 protein levels within a
specific range during terminal erythropoiesis. Our loss-of-function studies indicated that
decreasing Cpeb4 protein level below this range is detrimental to terminal erythropoiesis
(Figure 2, Figure 3). To further test the functional importance of maintaining Cpeb4 protein
levels within a specific range, we used retroviral transduction to constitutively express
Cpeb4 during terminal erythropoiesis, increasing both Cpeb4 mRNA and protein above their
normal levels in differentiating erythroblasts (Figure 6A, 6B). This resulted in a very similar
phenotype to Cpeb4 knockdown, as indicated by inhibition of cell proliferation (Figure 6C)
and cell division (Figure 6D), disappearance of cells in the S phase (Figure 6E, 6F), increase
of apoptotic cells (Figure 6G, 6H), and inability to form enucleated reticulocytes (Figure 6I,
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6J). Importantly, constitutive expression of only the C-terminal segment of Cpeb4 that
contains all the RNA-binding domains (Huang et al., 2006) does not affect terminal
erythroid differentiation, as indicated by the generation of enucleated reticulocytes (Figure
S6A–C). This indicates that the phenotypes we observed following Cpeb4 constitutive
expression are not caused by general RNA binding. In addition, these phenotypes are
specific to Cpeb4, because constitutive expression of another mRNA-binding protein,
Carhsp1, which is also dramatically induced during terminal erythropoiesis (Figure S1B),
did not inhibit terminal erythroid differentiation (Figure S6D–F). Collectively, these
observations revealed that maintaining Cpeb4 protein levels within a specific range is
important for terminal erythropoiesis.
Cpeb4 is Functionally Important in vivo
To explore the in vivo functional significance of Cpeb4, we obtained a Cpeb4 heterozygous
mouse from The International Knockout Mouse Consortium. The mouse was constructed by
inserting after the first exon of Cpeb4 a reporter-tagged sequence that contains a strong
transcriptional termination signal (pA signal) (Figure 7A) (Skarnes et al., 2011). We verified
the genotype of the knockout mouse by PCR (Figure 7B) and showed by Western blotting
that the level of Cpeb4 protein in homozygous knockout E14.5 fetal liver cells is below the
detection limit (Figure 7C). In breeding Cpeb4 heterozygous mice, wild-type, heterozygous,
and homozygous embryos were present at E14.5-E15.5 in the expected Mendelian ratio
(Figure 7D). However, of the 364 mice resulting from matings of the heterozygous Cpeb4
mice we genotyped at 2–3 weeks of age, only 5 were Cpeb4 homozygotes (Figure 7E),
while wild type and Cpeb4 heterozygous mice were born in the predicted Mendelian ratio.
Thus Cpeb4 homozygous mice die in utero after E15 or within 2 weeks of birth, strongly
arguing that Cpeb4 is required for normal development in vivo.
Two lines of evidence indicate that terminal erythropoiesis is impaired in the Cpeb4
knockout embryo, which may contribute to the death phenotype. First, Cpeb4 homozygous
knockout E14.5 fetal liver has significantly fewer terminally differentiating Ter119+
erythroblasts compared to those of wild type and the heterozygous embryos (Figure 7F).
Second, during terminal differentiation, Ter119+ erythroblasts cells gradually lose the
transferrin receptor (CD71); thus the relative level of CD71 on Ter119+ cells is a measure of
their progression during differentiation. We found that E14.5 Cpeb4 −/− Ter119+ cells
express higher levels of CD71 compared to Cpeb4 +/− and wild type Ter119+ cells (Figure
7G, 7H), indicating that the differentiation is compromised. Collectively, these observations
reveal that a deficiency of Cpeb4 in vivo causes a block in terminal erythroid differentiation.
DISCUSSION
Here we characterized a Cpeb4-mediated negative translational regulatory circuit that is
required for terminal erythropoiesis. This translational regulatory circuit is transcriptionally
induced by Gata1/Tal1 and is translationally negatively auto-regulated by Cpeb4 itself. We
argue that this regulatory circuit limits the level of Cpeb4 expression to within a specific
range required for this cell differentiation process.
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A previously reported Cpeb4 homozygous knockout mouse was reported to be normal (Tsai
et al., 2013); while our Cpeb4 homozygous knockout mouse has a clear late embryonic early
neonatal lethal phenotype. This phenotypic difference could arise from different methods
used to generate these knockout mice. Specifically, our mouse contains a strong
transcription termination signal after the first exon of Cpeb4, thereby, inhibiting the
generation of full length Cpeb4 mRNA. In contrast, Tsai et al deleted exon 2 of Cpeb4,
resulting in Cpeb4 transcripts with premature stop codons (PTCs). Since truncated proteins
can be generated from the PTCs and potential translational read-through at PTCs can
generate the full length protein (or longer truncated proteins), the Cpeb4 allele Tsai et al
generated may be hypomorphic, which can potentially explain the negative results of their
Cpeb4 knockout mouse. Our Cpeb4 −/− mice are lethal sometime after E14.5 and before 2
weeks after birth. Considering that Cpeb4 is expressed in multiple tissues and cells (e.g.
neurons, fetal liver erythroblasts, etc.) and Cpeb4 has been implicated in regulating meiosis
and mitotic cell-cycle progression (Igea and Mendez, 2010; Novoa et al., 2010), we
speculate that the lethal phenotype we observed may be due to defects in multiple tissues.
Nonetheless, the defects in terminal erythropoeisis we observed at E14.5 indicate that Cpeb4
is indeed required for proper terminal erythroid differentiation in vivo, and also suggest that
these erythropoiesis defects contribute to the lethal phenotype.
CPEB proteins are important translational regulators in diverse biological processes
(D’Ambrogio et al., 2013). Among the four family members, Cpeb4 has been implicated in
regulating neuronal activities, mitosis, meiosis, and cancer metastasis (Huang et al., 2006;
Igea and Mendez, 2010; Novoa et al., 2010; Ortiz-Zapater et al., 2012; Theis et al., 2003).
Interestingly, under these biological settings, Cpeb4 predominantly functions as a
translational activator by recruiting cytoplasmic poly(A) polymerase(s) to extend the
poly(A) tails on the 3’ ends of target mRNAs. For example, Cpeb4 activates target mRNA
translation in the activated oocyte and in pancreatic tumors (Ortiz-Zapater et al., 2012).
Here, however, we found that in terminal differentiating erythroblasts, the two known
cytoplasmic poly(A) polymerases are not expressed and that Cpeb4 functions as a
translation repressor. These observations are consistent with the notion that CPEB proteins
can both repress and activate mRNA translation.
Then what triggers the functional switch of Cpeb4 from a translation activator to a
repressor? We speculate that under different biological contexts post-translational
modifications and/or association with different protein complexes may mediate this
functional switch for Cpeb4. Such has been observed for Cpeb1, the best characterized
CPEB protein family member. Specifically, in the Xenopus oocyte, phosphorylation of
Cpeb1 by the Aurora kinase results in disassociation of Cpeb1 from a translation repression
complex and formation of a translation activation complex that recruits cytoplasmic
polyadenylases (D’Ambrogio et al., 2013; Fernandez-Miranda and Mendez, 2012).
Although Aurora kinase phosphorylation sites are absence in Cpeb4 (Theis et al., 2003), it
would be very interesting to explore the post-translational modification status of Cpeb4 and
the factors with which it associates in terminal erythroid cells as well as in other biological
settings.
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Mechanistically, we found that Cpeb4 interacts with the eIF3 complex to repress mRNA
translation in erythroid cells. This is different from the translational repression mechanism
employed by Cpeb1. In the Xenopus oocyte, Cpeb1 interacts with Maskin to interfere with
eIF4E’s binding to the 5’ end cap structure of mRNA, thereby inhibiting translation
initiation. Although Maskin (Tacc3 in mouse) is abundantly expressed in erythroid cells, we
did not observe an interaction with Cpeb4 in our mass spectrometry analyses. In addition,
Cpeb4 can inhibit certain IRES (HCV) mediated translational initiation, indicating that
Cpeb4 inhibits translation at the step(s) after 5’ end cap recognition. These results indicate
that Cpeb4 uses a previously uncharacterized mechanism to repress translation. We believe
that eIF3 is important for Cpeb4-mediated translation because Cpeb4 directly associates
with eIF3 complex. Furthermore, Cpeb4 represses eIF3-dependent translation (cap-
dependent translation and HCV-IRES mediated translation), but not eIF3-indepdent
translation (CrPV-IRES mediated translation). These observations indicate that the Cpeb4-
eIF3 interaction is functional in translational repression. eIF3 is the most complicated
translation initiation factor with 13 non-identical subunits in mammals that can regulate
translation initiation at multiple steps, including facilitation of 48S complex formation and
recycling of posttermination complexes (Hinnebusch, 2006, 2014; Pisarev et al., 2007).
Although we showed the Cpeb4 directly associates with the eIF3 complex, our data does not
indicate to which subunit(s) of eIF3 complex Cpeb4 directly binds. Thus it would be of great
interest in the future to characterize this Cpeb4-eIF3 interaction in detail, which will shed
light into the detailed molecular mechanisms of Cpeb4-mediated translation repression.
In terminal erythropoiesis, differentiating erythroblasts undergo dramatic morphological
changes that include chromatin condensation, decrease of nuclei size, and eventually exit of
the cell cycle and extrusion of the nucleus, resulting in enucleated reticulocytes. These
morphological changes require coordinated control of many factors involved in diverse
cellular processes. For example, many histone modifiers and transcription activators that
maintain active chromatin status need to be inhibited prior to or during chromatin
condensation, and cell cycle activators and DNA replication factors need to be
downregulated so that erythroid cells can exit the cell cycle. Interestingly, many Cpeb4
substrate mRNAs encode proteins involved in maintaining active chromatin structures (e.g.
Mll1–3 and Med13) and controlling cell cycle and DNA replication (e.g. Cdk6 and nucleic
acid helicases). Thus, it is tempting to speculate that Cpeb4 contributes to terminal
erythropoiesis by inhibiting the expression of those proteins that need to be downregulated
during this terminal cell differentiation process. In addition, we also observed that Cpeb4
binds a group of ubiquitin-domain containing proteins that have decreasing mRNA levels in
terminal erythroid differentiation. This observation suggests that down-regulation of these
protein degradation regulators may also be important for the generation of enucleated
reticulocytes.
As important translational regulators, CPEB proteins can form auto-regulatory loops to
control their own expression. In Drosophila oocytes, the Cpeb1 homologue, Orb, binds its
own mRNA to stimulate its translation, thereby forming a positive auto-regulatory loop at
the translational level to generate large amount of Orb protein that is required for stimulating
the translation of developmentally important mRNAs (Tan et al., 2001). In contrast, in
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erythroid cells, we found that Cpeb4 also binds its own mRNA, but instead Cpeb4 represses
translation of its own mRNA, thereby generating a negative auto-regulatory loop to limit
Cpeb4 protein levels within a specific range in terminal erythroblasts. Our functional studies
indicate that this negative regulatory circuit is important for erythroid differentiation, as
disruption of this loop both by loss-of-function and gain-of-function approaches block this
developmental process. We speculate that this negative auto-regulation mechanism
employed by Cpeb4 ensures that Cpeb4 protein will not accumulate to high levels that may
interfere with the translation of other mRNAs that are important for forming enucleated
reticulocytes (e.g. hemoglobin mRNA translation). Interestingly, Cpeb4 mRNA is also
dramatically induced in human terminal erythropoiesis (Merryweather-Clarke et al., 2011).
In addition, there are multiple U-rich motifs in the 3’UTRs from both mouse and human
Cpeb4 mRNAs, some of which are conserved between these two species. Thus, we
speculate that Cpeb4-mediated translational regulatory circuit is conserved between mouse
and human.
In summary, our study characterized a negative translational regulatory circuit that is
required for terminal erythropoiesis by inhibiting the translation of many genes normally
downregulated during terminal erythropoiesis. Interestingly, this translational regulatory
circuit is induced by well-characterized transcriptional regulatory networks, precisely
coupling translational and transcription regulation to modulate the expression of multiple
genes during terminal erythroid differentiation. We speculate that similar post-
transcriptional regulatory circuits exist in other mammalian cell differentiation processes.
Experimental Procedures
Plasmids and oligonucleotides
See supplementary experimental procedures.
Mouse strain and fetal liver cell analysis
All the mice used in this study were in a C57BL/6 background. The Cpeb4 heterozygous
knockout mouse (C57BL/6NTac-Cpeb4tm1a(EUCOMM)Wtsi/Cnrm) was imported from The
International Knockout Mouse Consortium. All animal experiments were in compliance
with regulations established by the the Whitehead Institute veterinary staff. To determine the
number of Ter119+ cells and the expression of CD71 in E14.5 mouse fetal liver, the cells
from a fetal liver were dissociated and resuspended in 300ul PBS. 100ul cells were used for
staining with antibodies to Ter119 (APC) and CD71 (FITC) as well as with PI. After
staining, the cells were washed and resuspended in 500ul PBS. Then 50ul CountBright
Absolute Counting Beads (Life technologies) (0.51 × 10e5 beads/ml) were added as a
standard for quantification of the cell number.
Tissue culture and retrovirus transduction
Erythroid progenitor cells were isolated from E14.5 C57BL/6 mouse fetal liver cells and
then cultured in maintenance and differentiation medium using the media and methods
described previously (Hu et al., 2011). A shRNA-expressing MSCV retroviral vector was
used for shRNA-mediated loss-of-function studies (Hu et al., 2011); pRetroX-IRES-
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DsRedExpress vector from Clontech was used for gain-of-function studies. All the
retroviruses were packaged in 293T cells via the pCL-eco packaging vector and then used to
transduce erythroid progenitor cells using the methods described previously (Hattangadi et
al., 2010). K562 cells were obtained from the ATCC, and MEL cells were a kind gift from
Dr. Barry Paw (Harvard Medical School).
RNA and protein analysis
The miRNeasy kit from Qiagen was used to extract total RNA from cells lines or primary
cells isolated by fluorescence-activated or magnetic-assisted cell sorting. In all RNA
isolation procedures, DNase I on-column digestion (Qiagen) was performed to remove
genomic DNA. cDNAs from the isolated RNAs were synthesized using the Superscript II
reverse transcriptase (Invitrogen) with random primers. Real-time PCR was performed on an
ABI Prism 7900 sequence detection system using SYBR Green PCR Master Mix (Applied
Biosystems). Proteins from target cells were extracted by RIPA buffer (50mM Tris-HCl
pH7.4, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 150mM NaCl, 2mM EDTA, 50mM
NaF). Then SDS-PAGE and Western blot were employed to detect target proteins using the
following antibodies: Cpeb4 (Abcam: ab83009), Gapdh (Santa Cruz biotechnology, Inc:
sc-32233), eIF3A (Cell Signaling: 2538), eIF3B (Abcam: ab133601).
Flow cyotometry analysis
The flow cytometry analyses were performed on a BD LSR ║ flow cytometer. All the
antibodies used for flow cytometry were from eBiosciences. Terminal erythroid
differentiation and enucleation was analyzed by the same methods as previously described
(Ji et al., 2008). Cell proliferation, cell division, cell cycle, and apoptosis were analyzed
using the CountBright Absolute Counting Beads (Life Technologies), the CellTrace CFSE
Cell Proliferation Kit (Life Technologies), Click-iT EdU Pacific Blue Flow Cytometry
Assay Kit (Life Technologies), and Annexin V Pacific Blue conjugate (Life Technologies),
respectively, in accordance with the corresponding protocols. For the cell proliferation
analysis, 10 uM CFSE dye (carboxyfluorescein diacetate succinimidyl ester) was used to
label cells for 10min at 37°C.
Polysome analysis and translation rate measurement
Polysome analysis was performed as described previously (Hu et al., 2009). In brief, 50
million MEL cells were lysed in polysome lysis buffer (10mM Tris-HCl pH7.4, 12mM
MgCl2, 100mM KCl, 1% TritonX-100, 100ug/ml cycloheximide). The cell lysate was
loaded onto a 10%-50% (w/v) linear sucrose-density gradient and then centrifuged at 37,000
rpm in a SW-41Ti rotor for 2 hours at 4°C. The gradient was then fractionated using a
Gradient Station (BioComp) coupled with a UV monitor (Bio-Rad EM-1). The RNA from
each fraction was isolated by the method described in Hu et al., 2009 (Hu et al., 2009). The
global translation rate was measured by using the Click-iT HPG Alexa Fluor-594 protein
synthesis assay kit (Life Technologies).
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Luciferase assays were performed in accordance with the protocol from the Dual-Luciferase
Reporter Assay System (Promega). Specifically, reporters and Cpeb4 expressing plasmids
were transfected into K562 cells using the Lipofectamine LTX reagent (Life Technologies),
and then luciferase assays were performed at 30 hours after transfection.
Affinity purification and immunoprecipitation
The Cpeb4 complex was purified from 50 million mouse fetal liver Ter119+ cells and 50
million K562 cells stably expressing Cpeb4-GFP using anti-Cpeb4 and anti-GFP (abcam
290) antibodies, respectively. 10ug antibody was used for each purification, and the
purification was performed in the presence and absence of RNaseA (200ug/ml) using a
magnetic IP and Co-IP kit from Pierce (Cat. 88805). The purified complex was resolved on
an SDS-PAGE gel followed by silver staining using reagents compatible with mass
spectrometry (Pierce Cat. 24600). After silver staining, each lane on the SDS-PAGE gel was
cut into 10 pieces for mass spectrometry to identify proteins at the Biopolymers &
Proteomics Lab at the Koch Institute of MIT. 5ug anti-eIF3A antibody was used to
immunoprecipitate the eIF3 complex from 20 million mouse fetal liver Ter119+ cells. The
purified complex was then subject to SDS-PAGE followed by Western blotting.
Bioinformatic analysis
RIP-Chip data from Affymetrix Mouse Gene ST Arrays were normalized by RMA using the
Affy package from Bioconductor. A custom probeset definition was used for processing the
arrays as defined by Dai et al.(Dai et al., 2005) such that one probeset represents one Entrez
Gene ID. The microarray results were deposited at the Gene Expression Omnibus with
accession number GSE57004.
To identify Cpeb4 binding motifs, refGene 3’UTR sequences were downloaded from the
UCSC Table Browser in Jan 2014, with repeat sequences masked to N. For each gene, all
the possible distinct 8mers were identified with the wordcount function in EMBOSS (Rice et
al., 2000). Fisher’s exact test was used to identify enriched 8mers in the Cpeb4 enriched
mRNAs relative to either the depleted mRNAs in the Cpeb4 RIP-Chip or a background set
of 17791 coding genes in both RNA-seq and RIP-Chip excluding the Cpeb4 enriched
mRNAs. To identify new motifs in the 227 enriched mRNAs in the Cpeb4 RIP-Chip, we
randomly selected the same number of enriched mRNAs from the 17791 background genes
1000 times. Each time, we ran Fisher’s exact test and looked for the over represented 8mer
motifs (FDR-corrected p value < 0.05) in the Cpeb4 bound mRNAs. Only the enriched
motifs in all 1000 replicates were used to draw the sequence logo with WebLogo (http://
weblogo.berkeley.edu).
The gene ontology analysis was performed using the DAVID Functional Annotation
Bioinformatics Microarray Analysis (http://david.abcc.ncifcrf.gov/)
Statistical analysis
Two-tailed Student’s t test was used to determine whether two sets of data are statistically
different from each other. All statistical analyses and the resulting graphs were performed
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and generated using GraphPad Prism version 6. Data are presented as mean ± standard
deviation (SD).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Cpeb4 is induced by Gata1/Tal1 and is required for terminal erythropoiesis
• Cpeb4 interacts with eIF3 to repress mRNA translation in erythroid cells
• Cpeb4 binds a large group of mRNAs, including its own, in erythroid cells
• Maintaining Cpeb4 level within a range is required for terminal erythropoiesis
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Figure 1. Cpeb4 is specifically induced in terminal erythroid differentiation
(A–B) E14 mouse fetal liver cells were fractionated into R1-R5 based on the cell surface
markers CD71 and Ter119. Cpeb4 mRNA was quantified in R1-R5 cells. (C) Different
lineages of terminal differentiated hematopoietic cells and progenitor cells (Lin-) were
isolated by magnetic assisted sorting from E14.5 mouse fetal liver followed by Cpeb4
mRNA quantification (mean ± SD; n = 3; * indicates p < 0.01 using two-tailed Student’s t
test). (D) Lin- cells isolated from E14.5 mouse fetal liver were cultured in erythroid
differentiation media and Cpeb4 protein levels were determined by Western blot at each
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indicated time point. The arrow indicates CPEB4 protein, the upper band (#) is a nonspecific
band. (E) The RNA-seq data of erythroid cells at different developmental stages and the
ChIP-seq datasets from mouse fetal liver Ter119+ cells at the Cpeb4 genomic region. See
also Figures S1 and S2.
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Figure 2. Cpeb4 is required for terminal erythroid differentiation
(A) Cpeb4 mRNA and Cpeb4 and Gapdh protein levels in shRNA knockdown cells and the
shRNA control cells. The arrow indicates Cpeb4 protein, and # indicates a non-specific
band. (B) Growth curves of Cpeb4 knockdown cells and the shRNA control cells in the
differentiation medium. (C) Measurement of the number of cell divisions at 24 hours and 48
hours in the differentiation medium. (D–E) The cell cycle profiles of Cpeb4 knockdown
cells and the shRNA control cells. (F–G) Apoptotic status of Cpeb4 knockdown cells and
the shRNA control cells was measured by annexin-V staining. (H–I) Quantification of genes
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induced and repressed in terminal erythroid differentiation by real-time RT-PCR. All the
results are from 3 independent measurements and presented as mean ± SD. * indicates p <
0.01 compared to the corresponding control (two-tailed Student’s t test). See also Figure S3.
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Figure 3. Cpeb4 knockdown blocks the generation of enucleated reticulocytes
(A) The generation of enucleated reticulocytes was analyzed in the Cpeb4 knockdown cells
and the shRNA control cells. Staining was with Ter119 and the Hoechst DNA- binding dye.
(B) The expression of cell surface markers Ter119 and CD71 was analyzed in Cpeb4
knockdown cells and the shRNA control cells. (C–D) Quantifications of relative efficiencies
of enucleation and the percentages of Ter119 and CD71 double positive cells in the Cpeb4
knockdown cells and the shRNA control cells. All the results are from 3 independent
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measurements and presented as mean ± SD. * indicates p < 0.01 using two-tailed Student’s t
test.
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Figure 4. Cpeb4 represses mRNA translation in erythroid cells by interacting with eIF3
(A) The translatability of the reporters in the presence and absence of λN-Cpeb4 was
determined by luciferase assay in K562 cells. (B) Co-immunoprecipitation of endogenous
eIF3 complex was performed in mouse fetal liver Ter119+ cells, followed by SDS-PAGE
and Western blotting to detect the proteins as indicated. (^) indicates a non-specific band;
(#) is likely to be degradation product(s) from eIF3A. (C) Quantification of Cpeb4 mRNA
and protein levels in MEL cells transduced by a Cpeb4 expressing retrovirus and control
retrovirus. (D–E) The polyribosome profiles (D) and the translation rates (E) of Cpeb4-
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expressing MEL cells were compared to those of the control cells. (F–G) IRES-based
bicistronic luciferase reporters (F) were transfected into K562 cells, and then luciferase
assays were performed in the presence and absence of ectopic expression of Cpeb4 to
measure the translation status of these reporters. All the results are from 3 independent
measurements and presented as mean ± SD. * indicates p < 0.01 and n.s. indicates p > 0.05
using two-tailed Student’s t test. See also Figure S4, Table S1.
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Figure 5. Cpeb4 represses target mRNA translation in differentiating erythroblasts
(A–B) The 3’UTRs from Cpeb4 RIP enriched mRNAs were compared to those from
depleted mRNAs to determine the enrichment of known CPEs (A), and then 8-nucleotide
motifs in the 3’UTRs from the enriched mRNAs was compared to randomly selected
mRNAs to identify the most over-represented motifs in the mRNAs associated with Cpeb4
(B). (C–D) RIP followed by real-time PCR was used to verify 16 Cpeb4-associated mRNAs
(C), and then gene ontology analysis was performed on all the Cpeb4-assocaited transcripts
identified from the Cpeb4 RIP-Chip (D). (E) The polyribosome profiles of Cpeb4
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overexpressing MEL cells and control cells. (F) The distribution of two Cpeb4 target
mRNAs, the endogenous Cpeb4 mRNA, and Cdk6 mRNA, and a control mRNA on a
sucrose-density gradient from MEL cells was determined by real-time RT-PCR in the
presence and absence of Cpeb4. All the results are from 3 independent measurements and
presented as mean ± SD. * indicates p < 0.01 using two-tailed Student’s t test. See also
Figure S5, Table S2.
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Figure 6. Constitutive expression of Cpeb4 inhibits terminal erythroid differentiation
(A–B) The Cpeb4 mRNA (A) and protein (B) levels in mouse primary fetal liver
erythroblasts constitutively expressing ectopic Cpeb4 and control cells. The arrow indicates
Cpeb4 protein, and # indicates a non-specific band. (C) Growth curves of Cpeb4 constitutive
expressing cells and control cells in the differentiation medium. (D) Measurement of the
number of cell divisions at 24 hours and 48 hours in the differentiation medium. (E–F) The
cell cycle profiles of Cpeb4 constitutive expressing cells and the control cells. (G–H)
Apoptotic status of Cpeb4 constitutive expressing cells and the shRNA control cells was
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measured by annexin-V staining. (I–J) Enucleation of Cpeb4 constitutive expressing cells
and the control cells. All the results are from 3 independent measurements and presented as
mean ± SD. * indicates p < 0.01 using two-tailed Student’s t test. See also Figure S6.
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Figure 7. Cpeb4 is functionally important in vivo
(A) Structures of Cpeb4 genomic region in wild type and Cpeb4 knockout mouse. P1, P2,
and P3 are PCR primers for genotyping. (B) Genotyping of wildtype (+/+), Cpeb4
heterozygous (+/−), and Cpeb4 knockout (−/−) mice by PCR. (C) Western blot of E14.5
total fetal liver cells isolated from wildtype, Cpeb4 heterozygous, and Cpeb4 homozygous
knockout embryos. (D) Genotyping of E14.5-E15.5 embryos from a mating of Cpeb4
heterozygotes. (E) Genotyping of 2–3 week old mice from matings of Cpeb4 heterozygotes.
(F) The quantification of Ter119+ cells in fetal livers from E14.5 embryos. The y axle is the
Hu et al. Page 31













scale relative to a known amount of added beads. * indicates p < 0.05 using two-tailed
Student’s t test. (G) CD71 and Ter119 staining of total E14.5 fetal liver cells. (H) CD71
expression levels in Ter119+ cells from E14.5 mouse fetal liver. The black arrow indicates
high CD71 level; the red arrow indicates low CD71 level. The results of (G, H) are
representative of E14.5 embryos from 4 sets of matings of Cpeb4 heterozygotes.
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